A comprehensive view of AstraZeneca AB. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.
AstraZeneca AB Galvanizes Industry Innovation and Supportive Healthcare with Milestones in Inclusion, Mental Wellbeing, Rare Disease Awareness, and Sustainable Manufacturing
Published:
March 28, 2024
by Industry Intelligence Inc.
|
AstraZeneca AB Champions Precision Medicine in Breast Cancer Treatment While Elevating CSR and Sustainability in the Pharmaceutical Industry
Published:
March 27, 2024
by Industry Intelligence Inc.
|
Executive Perspective: AstraZeneca CEO tells Bloomberg the company plans to manufacture drugs for the US and China markets separately amid rising geopolitical tensions threatening pharmaceutical supply chains
Published:
March 27, 2024
by FiercePharma
|
AstraZeneca Submits Patent Application for Pharmaceutical Formulations
Published:
March 27, 2024
by Pharmaceutical Patent News
|
US Patent Issued to AstraZeneca on March 26 for "Spirocyclic compounds" (British Inventor)
Published:
March 27, 2024
by U.S. Fed News
|
Ask us about our Sustainability & Social Responsibility market view